Ignite Creation Date:
2024-05-06 @ 5:51 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05451043
Status:
RECRUITING
Last Update Posted:
2024-06-12
First Post:
2022-07-05
Brief Title:
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors BLOCKED
Sponsor:
Organization:
AHS Cancer Control Alberta